In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.
References
1.
Hanker
AB
, Brewer
MR
, Sheehan
JH
, Koch
JP
, Sliwoski
GR
, Nagy
R
, et al An acquired HER2T798I gatekeeper mutation induces resistance to neratinib in a patient with HER2 mutant–driven breast cancer therapy
. Cancer Discov
2017
;7
:575
–85
.©2019 American Association for Cancer Research.
2019
American Association for Cancer Research.
RSS Feeds